seattle presentation

42
Dave Wolton VP manufacturing Large scale Mammalian plant design from 1980’s to present day 1

Upload: woltond

Post on 22-May-2015

414 views

Category:

Business


1 download

DESCRIPTION

Developments in facility design

TRANSCRIPT

Page 1: Seattle presentation

Dave WoltonVP manufacturing

Large scale Mammalian plant design from 1980’s to present day

1

Page 2: Seattle presentation

Overview

• CMC• Development of Large scale

Mammalian Monoclonal factories • 1985-1990• 1990-1995• 1995-2006• Present day

• Next Generation Factories• Impact of the new design on the rest of

the organisation• CMC prototyping of disposable harvest

systems• Summary

2

Page 3: Seattle presentation

CMC Biologics – Overview

Contract Manufacturer of Biological Therapeutics

utilizing MAMMALIAN & MICROBIAL CELL CULTURE TECHNOLOGIES

• Cell-line Development – CHEF1™ technology• Upstream/Downstream – process development and manufacture• Analysis, Characterization, Formulation, Quality and Regulatory

Target & Lead ID

Target & Lead ID

Pre-tox

Pre-tox

Tox Tox Phase I

Phase I

Phase II

Phase II

Phase III

Phase III

Commercial

Production

Commercial

Production

CMC Biologics

3

Page 4: Seattle presentation

Late 80’s

Development of Large scale Mammalian Monoclonal

factories

4

Page 5: Seattle presentation

Late 80’s

The dawn of automationSimple semi manual fermentorsValidation becoming more involvedContainment being actively pursuedCIP/SIP systems becoming more complicatedAutomation seen as reducing

Headcount, Turn-round timeOperator errors

5

Page 6: Seattle presentation

Early 90’s

6

Page 7: Seattle presentation

Early 90’s

Some companies begin to realise complex automation systems have drawbacks.

They see increasing HeadcountComplexity of plantTurn-round timesComplexity of investigations (variables)Facility build costsFacility construction times

7

Page 8: Seattle presentation

Additive manifold

Air Out

Air to headspace

Air to spargerJacket heat exchanger Sample device

8

Early 90’s

Example of early 90’s Bioreactor

Page 9: Seattle presentation

Late 90’s to 2006

9

Page 10: Seattle presentation

Late 90’s to 2006

Some companies start to reduce cost by simplifying.

Stainless steel reactors are simplified by reducing numbers of valves/items.

Disposables reduce the need for CIP/SIP.

InnovationsTubing weldersLynx valvesPod filtersWave reactorsSUM’s

10

Page 11: Seattle presentation

The fastest CIP?

Reduce the number of inlets that need cleaning.

How to simplify stainless vessels

11

Page 12: Seattle presentation

How to simplify stainless vessels

Additive manifolds

12

Page 13: Seattle presentation

How to simplify stainless vessels

Air Out

13

Page 14: Seattle presentation

How to simplify stainless vessels

Air To Head Space

14

Page 15: Seattle presentation

How to simplify stainless vessels

Air To Sparger

15

Page 16: Seattle presentation

How to simplify stainless vessels

16

Pre Lynx Modifications

Approximately 70

Post Lynx modifications

Approximately 30

Number of sterile boundary elastomers

Page 17: Seattle presentation

Present Day

17

Page 18: Seattle presentation

Single use bioreactors

18

Page 19: Seattle presentation

Present day

Elan’s plant design breaks new ground (2008).

Large scale disposables are widely accepted

2000L reactors are launched onto the market (2010)

19

Page 20: Seattle presentation

Next generation factories

20

Page 21: Seattle presentation

The Facility – the next generation of plant after élan

2g/l monoclonal antibody- fed batch

10 x 4,000L batches per month

80 cm column, 3 cycles

21

= 2 x 12,000L stainless plant

Page 22: Seattle presentation

The Facility – The next generation after Élan

Foot print Comparison

Media prep.Buffer prep.

Bioreactors.

Purification

XX

22

Page 23: Seattle presentation

The Facility – the next generation of plant after élan

How do you make media next to the bioreactor without contaminating the

room with powder?

23

Page 24: Seattle presentation

Contained media mixing – GEA

24

Page 25: Seattle presentation

Contained media mixing – Hyclone

Hyclone Powdertainer

25

Page 26: Seattle presentation

Contained media mixing - Lormac

26

Page 27: Seattle presentation

Use of Buffer towers in Downstream worked example

27

Page 28: Seattle presentation

The Facility – the next generation of plant after élan

How do you make and store up to 6,000L of buffer and not use large numbers of

buffer bags?

28

Page 29: Seattle presentation

AnswerBy positioning 2,000L buffer towers close to the column and

‘topping up’ from 1,000L single use mixers.

Buffer towers - Prototype

Prototype

29

Page 30: Seattle presentation

Buffer Modeling

Buffer storage in 1000L Buffer hold bags VS

Five 2,000L buffer towers; replaced monthly

Buffer b Adsorption chromatography buffer - Max 4,000L

Buffer a Ultrafiltration Diafiltration buffer – Max 6,000L

Buffer towers - worked example

30

Page 31: Seattle presentation

The Facility – the next generation of plant after élan

Buffer b

Buffer a

31

Page 32: Seattle presentation

Waste comparison example

32

Page 33: Seattle presentation

Impact of the new design on the organisation

33

Page 34: Seattle presentation

The Facility – the next generation of plant after élan

Cell Culture12 technicians – 9:00 to 5:30 – 7 days a week

Purification24-36 technicians – 24hr – 7 days a week

Buffer - Media0 technicians

HR1 manager – 1 admin.

QCNo change from current factories

Maintenance1 HVAC, 1 Utilities, 2 Equipment/Cal

Plant Automation0IT

3-4, Electronic batch records preferableStoresSame as current factories

34

Page 35: Seattle presentation

CMC prototyping of disposable harvest systems

35

Page 36: Seattle presentation

Integrated 500L depth filter system

500L

36

Page 37: Seattle presentation

Integrated 500L depth filter system

37

Page 38: Seattle presentation

38

Integrated 2000L depth filter system

2000L

Page 39: Seattle presentation

Integration harvest hollow fibber into concentrated fed batch system

Connections for the harvest hollow fiber

39

Page 40: Seattle presentation

Summary

40

Page 41: Seattle presentation

Industry trends and expectations

Reduced production costs

Decreased capital investments

More flexible plants with faster turnaround time

Risk management and mitigation

Increased control over products, processes, timelines

Close cooperation, partnership, strategic alliances

Culture with a continuous improvements mindset

Source: www.contractpharma.com, article October 2010: Biotechnology Trends & Outsourcing, Lou Schmukler and John Korte, Pfizer Global Manufacturing

Reduced facility footprintS

ing

le u

se

41

Page 42: Seattle presentation

What next at CMC……..

Installation of 2000L disposable Bioreactor/Harvest

capacity in 2011

42